» Articles » PMID: 12963373

Contributions of CDR3 to V H H Domain Stability and the Design of Monobody Scaffolds for Naive Antibody Libraries

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2003 Sep 10
PMID 12963373
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Camelids produce functional antibodies devoid of light chains. Autonomous heavy chain variable (V(H)H) domains in these molecules have adapted to the absence of the light chain in the following ways: bulky hydrophobic residues replace small aliphatic residues in the former light chain interface, and residues from the third complementarity-determining region (CDR3) pack against the framework and stabilize the global V(H)H domain fold. To determine the specific roles of CDR3 residues in framework stabilization, we used nai;ve phage-displayed libraries, combinatorial alanine-scanning mutagenesis and biophysical characterization of purified proteins. Our results indicate that in the most stable scaffolds, the structural residues in CDR3 reside near the boundaries of the loop and pack against the framework to form a small hydrophobic core. These results allow us to differentiate between structural CDR3 residues that should remain fixed, and CDR3 residues that are tolerant to substitution and can therefore be varied to generate functional diversity within phage-displayed libraries. These methods and insights can be applied to the rapid design of heavy chain scaffolds for the identification of novel ligands using synthetic, antibody-phage libraries. In addition, they shed light on the relationships between CDR3 sequence diversity and the structural stability of the V(H)H domain fold.

Citing Articles

Single domain antibody: Development and application in biotechnology and biopharma.

Yu T, Zheng F, He W, Muyldermans S, Wen Y Immunol Rev. 2024; 328(1):98-112.

PMID: 39166870 PMC: 11659936. DOI: 10.1111/imr.13381.


Development of a new affinity maturation protocol for the construction of an internalizing anti-nucleolin antibody library.

Ribeiro R, Moreira J, Goncalves J Sci Rep. 2024; 14(1):10608.

PMID: 38719911 PMC: 11079059. DOI: 10.1038/s41598-024-61230-z.


Physicochemical differences between camelid single-domain antibodies and mammalian antibodies.

Eskier N, Eskier D, Firuzan E, Uzunlar S Turk J Biol. 2024; 47(6):423-436.

PMID: 38681780 PMC: 11045209. DOI: 10.55730/1300-0152.2676.


Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions.

Mullin M, McClory J, Haynes W, Grace J, Robertson N, van Heeke G MAbs. 2024; 16(1):2341443.

PMID: 38666503 PMC: 11057648. DOI: 10.1080/19420862.2024.2341443.


Conformational features and interaction mechanisms of V H antibodies with β-hairpin CDR3: A case of Nb8-HigB2 interaction.

Yamamoto K, Nagatoishi S, Matsunaga R, Nakakido M, Kuroda D, Tsumoto K Protein Sci. 2023; 32(12):e4827.

PMID: 37916305 PMC: 10661080. DOI: 10.1002/pro.4827.